Keith Foster, Sutura Therapeutics

"We don't just want to give kids with rare diseases hope, we want to give them a better life and better treatments." Keith Foster is the Chief Scientific Officer of Sutura Therapeutics, a company he founded to develop precision gene therapies for rare diseases, starting with Duchenne's Muscular Dystrophy. Sutura is a genuinely patient-focused company, and if you've ever wondered what patient-centricity truly is, Keith's interview is a must-listen. Enjoy!